What are the implications of the TGA’s stricter approach to cosmetic treatment promotions? And how might the TGA’s regulatory approach interact with the law of negligence that requires practitioners to warn patients of inherent material risks?

Today I’ve written a short reflection on AHPRA and the Medical Board of Australia’s (MBA) proposed options to reform the regulation of ‘late-career medical practitioners’ — ie, doctors over 70 years old — by requiring them to undergo regular health assessments. I will mostly let my short analysis published in the Conversation, speak for itself. […]

In late November, I presented a paper via video link to the Australasian Association of Bioethics and Heath Law (AABHL) on ‘risk-based regulation.’ The abstract for that paper was as follows: What risk? A critical analysis of risk-based regulation of therapeutic goods, from stem cell medicine to osseointegration devices Therapeutic goods (medicines, biologicals and devices) […]

The proposed ACT approval model Recently, I was interviewed by the young journalistic team at SIX News Australia about a Bill that the ACT Government introduced into its single-house Parliament in late March 2023. As I see it, the proposed Bill, if passed, will be transformative. And in a good way. It will require interventions […]